Segmentation by type categorises the market into four solution families that underpin the overall offering. Integrated platforms combine automated sample preparation, amplification, and detection in a single instrument, delivering end‑to‑end workflow efficiency and capturing a premium price tier. Consumables encompass reagents, kits, and cartridges; their recurring purchase model generates the bulk of recurring revenue and is highly sensitive to assay volume growth. Software analytics provides bioinformatic pipelines, variant interpretation, and reporting modules, increasingly monetised through subscription licences and value‑added services. Service packages include maintenance contracts, proficiency testing, and remote technical support, which stabilise cash flow and reinforce customer lock‑in. By dissecting the market into these types, analysts can attribute revenue shares to hardware, consumable turnover, data‑centric services, and ancillary support, offering a granular view of the Comprehensive Solution for Molecular Testing market taxonomy.